š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This project aims to clarify the role non-motor symptoms in the development...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT02650843
Treatments Being Tested
The purpose of this study is to investigate the utility of dopamine transpo...
Status
Completed
Location
Institute for Neurodegenerative Disorders
Start Date
2006-11
Trial ID
NCT00404170
Treatments Being Tested
This study will examine changes in brain dopamine transporter activity befo...
Status
Completed
Location
Depression Research Unit - University of Pennsylvania
Start Date
2005-10
Trial ID
NCT00655057
The general aim of this research project is to determine the relationships ...
Status
Completed
Location
Groupe Hospitalier Pellegrin - C.H.U. de Bordeaux
Start Date
2009-05
Trial ID
NCT00917709
Treatments Being Tested
After a screening evaluation including baseline clinical laboratory testing...
Status
Completed
Location
Molecular NeuroImaging
Start Date
2006-11
Trial ID
NCT00397228
Treatments Being Tested
This is a multicenter, open-label, non-controlled, non-randomized, phase 3 ...
Status
Completed
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2020-06-28
Trial ID
NCT04193527
Treatments Being Tested
This is a observational, multi-center study to assess progression of clinic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2010-06
Trial ID
NCT01141023
Treatments Being Tested
Multiple system atrophy (MSA) is a rare and fatal neurodegenerative disease...
Status
Completed
Location
CHU de Bordeaux
Start Date
2020-05-26
Trial ID
NCT04229173
DaTscanTM Ioflupane I123, a radiopharmaceutical will be used as an adjunct ...
Status
Completed
Location
University of Kentucky Department of Neurology
Start Date
2018-01-19
Trial ID
NCT03531086
Treatments Being Tested
Previous studies showed that a dose of 8 millicuries of Altropane was appro...
Status
Terminated
Location
Johns Hopkins University
Start Date
2023-04-24
Trial ID
NCT05636852
Treatments Being Tested